Skip to main content
. 2022 Apr 28;12:866293. doi: 10.3389/fonc.2022.866293

Figure 4.

Figure 4

Evaluation of prognostic responses of ER status in CTCs and corresponding IHC results to endocrine therapy. The PFS between BC patients with ER-positive CTCs and those with ER-negative CTCs.